The prevention of schizophrenia

References

• Adams W, Kendell RE, Hare EH, Munk JP. Epidemiological evidence that maternal influenza contributes to the aetiology of schizophrenia: An analysis of Scottish, English and Danish data. British Journal of Psychiatry 1993; 163: 522–534
   PubMed Web of Science ®Google Scholar
• Andréasson S, Allebeck P, Engström A, Rydberg U. Cannabis and schizophrenia: A longitudinal study of Swedish conscripts. Lancet 1987; 2(8574)1483–1486
   PubMed Web of Science ®Google Scholar
• Aro S, Aro H, Keskimaeki I. Socio-economic mobility among patients with schizophrenia or major affective disorder: A 17-year retrospective follow-up. British Journal of Psychiatry 1995; 166: 759–767
   PubMedGoogle Scholar
• Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE. Cannabis use in adolescence and risk for adult psychosis: Longitudinal prospective study. BMJ 2002; 325: 1212–1213
   PubMed Web of Science ®Google Scholar
• Bai O, Wei Z, Lu W, Bowen R, Keegan D, Li XM. Protective effects of atypical antipsychotic drugs on PC12 cells after serum withdrawal. Journal of Neuroscience Research 2002; 69(2)278–283
   PubMed Web of Science ®Google Scholar
• Bechdolf A, Ruhrman S, Wagner M, Kuhn KU, Janssen B, Bottlender R, et al. Interventions in the initial prodromal states of psychosis in Germany: Concept and recruitment. British Journal of Psychiatry 2005a; 187(suppl. 48)s45–48
   Web of Science ®Google Scholar
• Bechdolf A, Veith V, Schwarzer D, Schormann M, Stamm E, Janssen B, et al. Cognitive-behavioural therapy in the pre-psychotic phase: An exploratory study. Psychiatry Research 2005b; 136: 251–55
   PubMedGoogle Scholar
• Bechdolf A, Wagner M, Veith V, Ruhrmann R, Janssen B, Bottlender R, et al. Multiple-risk cohorts and segmenting risk as solutions to the problem of false positives in risk for the major psychoses. Psychiatry 1992; 55: 370–381
   PubMedGoogle Scholar
• Berger GE, Wood S, McGorry PD. Incipient neurovulnerability and neuroprotection in early psychosis. Psychopharmacology Bulletin 2003; 37: 79–101
   PubMedGoogle Scholar
• Berger G, Dell’Olio M, Amminger P, Cornblatt B, Phillips L, Yung A, et al. Neuroprotection in emerging psychotic disorders. Early Intervention in Psychiatry, (in press)
   Google Scholar
• Birchwood M, Todd P, Jackson C. Early intervention in psychosis. The critical period hypothesis. British Journal of Psychiatry 1998; 172(suppl. 33)s53–s59
   PubMed Web of Science ®Google Scholar
• Bottlender R, Moller HJ. The impact of the duration of untreated psychosis on short- and long-term outcome in schizophrenia. Current Opinion in Psychiatry 2003; 16(Suppl. 2)S39–S43
   Google Scholar
• Bowers M. The onset of psychosis–A diary account. Psychiatry 1965; 28(4)346–358
   PubMedGoogle Scholar
• Boydell J, van Os J, Lambri M, Castle D, Allardyce J, McCreadie RG, et al. Incidence of schizophrenia in south-east London between 1965 and 1997. British Journal of Psychiatry 2003; 182: 45–49
   PubMedGoogle Scholar
• Brown CH, Liao J. Principles for designing randomized preventive trials in mental health: An emerging developmental epidemiology paradigm. American Journal of Community Psychology 1999; 27(5)673–710
   PubMed Web of Science ®Google Scholar
• Buckley PF. The clinical stigmata of aberrant neurodevelopment in schizophrenia. Journal of Nervous and Mental Disease 1998; 186: 79–86
   PubMedGoogle Scholar
• Chapman LJ, Chapman JP. The search for symptoms predictive of schizophrenia. Schizophrenia Bulletin 1987; 13(3)497–503
   PubMed Web of Science ®Google Scholar
• Cohen P, Cohen J. The clinician's illusion. Archives of General Psychiatry 1984; 41(12)1178–1182
   PubMed Web of Science ®Google Scholar
• Cornblatt B, Lencz T, Obuchowski M. The schizophrenia prodrome: Treatment and high-risk perspectives. Schizophrenia Research 2002; 54: 177–186
   PubMed Web of Science ®Google Scholar
• Craig TK, Garety PA, Power P, Rahaman N, Colbert S, Fornells–Ambrojo M, et al. The Lambeth Early Onset (LEO) team: Randomised controlled trial of the effectiveness of specialised care for early psychosis. British Medical Journal 2004; 329: 1067–1072
   PubMed Web of Science ®Google Scholar
• Cuijpers P. Examining the effects of prevention programs on the incidence of new cases of mental disorders: The lack of statistical power. American Journal of Psychiatry 2003; 160: 1385–1391
   PubMed Web of Science ®Google Scholar
• Davidson M, Reichenberg A, Rabinowitz J, Weiser M, Kaplan Z, Mark M. Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. American Journal of Psychiatry 1999; 156: 1328–1335
   PubMed Web of Science ®Google Scholar
• Docherty JP, Van Kammen DP, Siris SG, Marder SR. Stages of onset of schizophrenic psychosis. American Journal of Psychiatry 1978; 135(4)420–426
   PubMedGoogle Scholar
• Done DJ, Sacker A, Crow TJ. Childhood antecedents of schizophrenia and affective illness: Intellectual performance at ages 7 and 11. Schizophrenia Research 1994; 11: 96
   Google Scholar
• Done DJ, Crow TJ, Johnstone EC, Sacker A. Childhood antecedents of schizophrenia and affective illness: Social adjustment at ages 7 and 11. British Medical Journal 1994; 309: 699–703
   PubMed Web of Science ®Google Scholar
• Donlon PT, Blacker KH. Stages of schizophrenic decompensation and reintegration. Journal of Nervous and Mental Disease 1973; 157: 200–209
   PubMed Web of Science ®Google Scholar
• Eaton WW, Badawi M, Melton B. Prodromes and precursors: Epidemiologic data for primary prevention of disorders with slow onset. American Journal of Psychiatry 1995; 152: 967–972
   PubMed Web of Science ®Google Scholar
• Eaton W, Harrison G. Life chances, life planning, and schizophrenia: A review and interpretation of research on social deprivation. International Journal of Mental Health 2001; 30: 58–81
   Google Scholar
• Edwards J, Harris MG, Bapat S. Developing services for first-episode psychosis and the critical period. British Journal of Psychiatry 2005; 187(suppl. 48)s91–97
   Google Scholar
• Edwards J, McGorry PD. Implementing early interventions in psychosis: A guide to establishing early psychosis services. Martin Dunitz, London 2002
   Google Scholar
• Early Psychosis Prevention & Intervention Centre. EPPIC early psychosis training pack. EPPIC, Melbourne 1997
   Google Scholar
• Faergman P. Psychogenic psychoses. Butterworth, London 1963
   Google Scholar
• Fava GA, Kellner R. Staging: A neglected dimension in psychiatric classification. Acta Psychiatrica Scandinavica 1993; 87(4)225–230
   PubMedGoogle Scholar
• Frangou S, Murray RM. Schizophrenia2nd. Martin Dunitz, London 2000
   Google Scholar
• Friis S, Vaglum P, Haahr U, Johannessen JO, Larsen TK, Melle I, et al. Effect of an early detection programme on duration of untreated psychosis: Part of the Scandinavian TIPS study. British Journal of Psychiatry 2005; 48(Suppl.)s29–s32
   Google Scholar
• Garety PA, Craig TK, Dunn G, Fornells-Ambrojo M, Colbert S, Rahaman N, et al. Specialised care for early psychosis: Symptoms, social functioning and patient satisfaction: Randomised controlled trial. British Journal of Psychiatry 2006; 188: 37–45
   PubMed Web of Science ®Google Scholar
• Geddes J, Lawrie S. Obstetric complications and schizophrenia. British Journal of Psychiatry 1995; 167: 786–793
   PubMed Web of Science ®Google Scholar
• Gleeson J, Larsen TK, McGorry PD. Psychological treatment in pre- and early psychosis. Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry 2003; 31: 229–245
   PubMedGoogle Scholar
• Greenfield S, Strakowski S, Tohen M, Batson S, Kolbrener M. Child abuse in first episode psychosis. British Journal of Psychiatry 1994; 64: 831–834
   Google Scholar
• Gross G. The onset of schizophrenia. Schizophrenia Research 1997; 28: 187–198
   PubMed Web of Science ®Google Scholar
• Gross G, Huber G. The true onset of schizophrenia in its meaning for the view of the disorder. Neurology, Psychiatry and Brain Research 1996; 4: 93–102
   Google Scholar
• Hafner H, Maurer K, Trendler G, An Der Heiden W, Schmidt M, Konnecke R. Schizophrenia and depression: Challenging the paradigm of two separate diseases–a controlled study of schizophrenia, depression and healthy controls. Schizophrenia Research 2005; 77(1)11–24
   PubMed Web of Science ®Google Scholar
• Hafner H, Riecher-Rossler A, An Der Heiden W, Maurer K, Fatkenheuer B, Loffler W. Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia. Psychological Medicine 1993; 23(4)925–940
   PubMed Web of Science ®Google Scholar
• Haroun N, Dunn L, Haroun A, Cadenhead KS. Risk and protection in prodromal schizophrenia: Ethical implications for clinical practice and future research. Schizophrenia Bulletin 2006; 32(1)166–178
   PubMedGoogle Scholar
• Harrigan SM, McGorry PD, Krstev H. Does treatment delay in first-episode psychosis really matter?. Psychological Medicine 2003; 33(1)97–110
   PubMed Web of Science ®Google Scholar
• Harris MG, Henry LP, Harrigan SM, Purcell R, Schwartz OS, Farrelly SE, et al. The relationship between duration of untreated psychosis and outcome: An eight-year prospective study. Schizophrenia Research 2005; 79: 85–93
   PubMed Web of Science ®Google Scholar
• Harris MG, Burgess PM, Chant D, Pirkis JE, McGorry PD. Impact of specialised first-episode psychosis treatment on suicide following initial presentation to mental health services: Retrospective cohort study. Schizophrenia Research 2006; 81(Suppl. 1)s307–s308
   Google Scholar
• Heinrichs DW, Cohen BP, Carpenter WT, Jr. Early insight and the management of schizophrenic decompensation. Journal of Nervous and Mental Disease 1985; 173(3)133–138
   PubMedGoogle Scholar
• Herz MI, Melville C. Relapse in schizophrenia. American Journal of Psychiatry 1980; 137: 801–805
   PubMed Web of Science ®Google Scholar
• Jackson C, Birchwood M. Early intervention in psychosis: Opportunities for secondary prevention. British Journal of Psychology 1996; 35: 487–502
   Google Scholar
• Jackson HJ, McGorry PD, Edwards J, Hulbert C, Henry L, Francey S, et al. Cognitively oriented psychotherapy for early psychosis (COPE). British Journal of Psychiatry 1998; 172(suppl. 33)s93–s100
   Google Scholar
• Jauch DA, Carpenter WT, Jr. Reactive psychosis. I. Does the pre-DSM-III concept define a third psychosis?. Journal of Nervous and Mental Disease 1988; 176(2)72–81
   PubMedGoogle Scholar
• Johannessen JO, McGlashan TH, Larsen TK, Horneland M, Joa I, et al. Early detection strategies for untreated first-episode psychosis. Schizophrenia Research 2001; 51: 39–46
   PubMed Web of Science ®Google Scholar
• Jolley S, Garety P, Carig T, Dunn G, White J, Aitken M. Cognitive therapy in early psychosis: A pilot randomised controlled trial. Behavioural and Cognitive Psychotherapy 2003; 160: 473–478
   Google Scholar
• Jorgensen P, Nordentoft M, Abel MB, Gouliaev G, Jeppesen P, Kassow P. Early detection and assertive community treatment of young psychotics: The OPUS Study. Rationale and design of the trial. Social Psychiatry and Psychiatric Epidemiology 2000; 35(7)283–287
   PubMed Web of Science ®Google Scholar
• Jorm A, Korten A, Jacomb P, Christensen H, Rodgers B, Pollitt P. ‘Mental health literacy’: A survey of the public's ability to recognise mental disorders and their beliefs about the effectiveness of treatment. Medical Journal of Australia 1997; 166: 182–186
   PubMed Web of Science ®Google Scholar
• Kaplan HI, Sadock BJ, Grebb JA. Kaplan and Sadock's synopsis of psychiatry. Williams & Wilkins, Baltimore 1994
   Google Scholar
• Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 2005; 62: 593–602
   PubMed Web of Science ®Google Scholar
• Keys, Young. Research and consultation among young people on mental health issues, final report. Commonwealth Department of Health and Family Services, Canberra 1997
   Google Scholar
• Killackey E, Yung AR. Effectiveness of early intervention in psychosis. Current Opinion in Psychiatry 2007; 20: 121–125
   PubMed Web of Science ®Google Scholar
• Killackey EJ, Jackson HJ, Gleeson J, Hickie IB, McGorry PD. Exciting career opportunity beacons! Early intervention and vocational rehabilitation in first-episode psychosis: Employing cautious optimism. Australian and New Zealand Journal of Psychiatry 2006; 40: 951–962
   PubMed Web of Science ®Google Scholar
• Klosterkotter J, Ebel H, Schultze-lutter F, Steinmeyer EM. Diagnostic validity of basic symptoms. European Archives of Psychiatry and Clinical Neurosciences 1996; 246: 147–154
   PubMed Web of Science ®Google Scholar
• Klosterkotter J, Gross G, Huber G, Wieneke A, Steinmeyer EM, Schultze-lutter F. Evaluation of the 'Bonn Scale for the Assessment of Basic Symptoms–BSABS' as an instrument for the assessment of schizophrenia proneness: A review of recent findings. Neurology, Psychiatry and Brain Research 1997; 5: 137–150
   Google Scholar
• Klosterkotter J, Hellmich MI, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Archives of General Psychiatry 2001; 58: 158–164
   PubMed Web of Science ®Google Scholar
• Klosterkotter J, Ruhrmann S, Schultze-Lutter F, Salokangas RK, Linszen D, Birchwood M, et al. The European Prediction of Psychosis Study (EPOS): Integrating early recognition and intervention in Europe. World Psychiatry 2005; 3: 1–7
   Google Scholar
• Kraemer HC, Kazdin AE, Offord DR, Kessler RC, Jensen PS, Kupfer DJ. Coming to terms with the terms of risk. Archives of General Psychiatry 1997; 54: 337–343
   PubMed Web of Science ®Google Scholar
• Larsen TK. The transition from premorbid period to psychosis: How can it be described?. Acta Psychiatrica Scandinavica 2002; 106(Suppl.)s10–s11
   Google Scholar
• Larsen TK, Melle I, Auestad B, Friis S, Haahr U, Johannessen JO, et al. Early detection of first-episode psychosis: The effect on 1-year outcome. Schizophrenia Bulletin 2006; 32: 758–764
   PubMed Web of Science ®Google Scholar
• Lencz T, Smith CW, Auther AM, Correll CU, Cornblatt BA. The assessment of ‘prodromal schizophrenia’: Unresolved issues and future directions. Schizophrenia Bulletin 2003; 29(4)717–728
   PubMedGoogle Scholar
• Lewis S, Tarrier N, Haddock G, Bentall R, Kinderman P, Kingdon D, et al. Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: Acute-phase outcomes. British Journal of Psychiatry 2002; 43(Suppl.)s91–s97
   Google Scholar
• Malla AK, Norman RM, Manchanda R, Ahmed MR, Scholten D, Harricharan R, et al. One year outcome in first episode psychosis: Influence of DUP and other predictors. Schizophrenia Research 2002; 54(3)231–242
   PubMed Web of Science ®Google Scholar
• Manji HK, Moore GJ, Chen G. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: A role for neurotrophic and neuroprotective effects in manic depressive illness. Journal of Clinical Psychiatry 2000; 61(Suppl. 9)s82–s96
   PubMed Web of Science ®Google Scholar
• Marshall M, Lewis S, Lockwood Au, Drake R, Jones P, Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: A systematic review. Archives of General Psychiatry 2005; 62: 975–983
   PubMed Web of Science ®Google Scholar
• Mason O, Startup M, Halpin S, Schall U, Conrad A, Carr V. Risk factors for transition to first episode psychosis among individuals with ‘at-risk mental states’. Schizophrenia Research 2004; 71(2–3)227–237
   PubMed Web of Science ®Google Scholar
• McGlashan TH, Johannessen JO. Early detection and intervention with schizophrenia: Rationale. Schizophrenia Bulletin 1996; 22(2)201–222
   PubMed Web of Science ®Google Scholar
• McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller T, Woods SW, et al. Randomized, double-blind trial of Olanzapine versus placebo in patients prodromally symptomatic for psychosis. American Journal of Psychiatry 2006; 163: 790–799
   PubMed Web of Science ®Google Scholar
• McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller TJ, Woods SW, et al. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design. Schizophrenia Research 2003; 61(1)7–18
   PubMedGoogle Scholar
• McGorry PD. Paradigm failure in functional psychosis: Review and implications. Australian and New Zealand Journal of Psychiatry 1991; 25(1)43–55
   PubMedGoogle Scholar
• McGorry PD, Singh BS. Schizophrenia: Risk and possibility. Handbook of preventive psychiatry, B Raphael, GD Burrows. Elsevier, Amsterdam 1995; 492–514
   Google Scholar
• McGorry PD, Edwards J, Mihalopoulos C, Harrigan SM, Jackson HJ. EPPIC: An evolving system of early detection and optimal management. Schizophrenia Bulletin 1996; 22: 305–326
   PubMed Web of Science ®Google Scholar
• McGorry PD, Yung AR, Phillips LJ. ‘Closing in’: What features predict the onset of first-episode psychosis within an ultra-high-risk group?. The early stages of schizophrenia, RB Zipursky, SC Schulz. American Psychiatric Publishing, Inc, Washington, DC 2002a; 3–31
   Google Scholar
• McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Archives of General Psychiatry 2002b; 59(10)921–928
   PubMedGoogle Scholar
• McGorry PD, Yung AR. Early intervention in psychosis: An overdue reform. Australian and New Zealand Journal of Psychiatry 2003; 37(4)393–398
   PubMed Web of Science ®Google Scholar
• McGorry PD, Yung AR, Phillips LJ. The ‘close-in’ or ultra high risk model: A safe and effective strategy for research and clinical intervention in prepsychotic mental disorder. Schizophrenia Bulletin 2003; 29(4)771–790
   PubMedGoogle Scholar
• McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging of psychiatric disorders: A heuristic framework for choosing earlier, safer and more effective interventions. Australian & New Zealand Journal of Psychiatry 2006; 40: 616–622
   PubMed Web of Science ®Google Scholar
• McNaught AS, Jeffreys SE, Harvey CA, Quayle AS, King MB, Bird AS. The Hampstead Schizophrenia Survey 1991: II. Incidence and migration near London. British Journal of Psychiatry, 170: 307–311
   PubMedGoogle Scholar
• McNeil T. Perinatal risk factors and schizophrenia: Selective review and methodological concerns. Epidemiology Review 1995; 17(1)107–112
   PubMed Web of Science ®Google Scholar
• McNeil TF, Cantor-Graae E. Minor physical anomalies and obstetric complications in schizophrenia. Australian & New Zealand Journal of Psychiatry 2000; 34: S65–S73
   Web of Science ®Google Scholar
• Meares A. The diagnosis of prepsychotic schizophrenia. Lancet 1959; i: 55–59
   Google Scholar
• Melle I, Larsen TK, Haahr U, Friis S, Johannessen JO, Opjordsmoen S, et al. Reducing the duration of untreated first-episode psychosis: Effects on clinical presentation. Archives of General Psychiatry 2004; 61(2)143–150
   PubMed Web of Science ®Google Scholar
• Mihalopoulos C, McGorry PD, Carter RC. Is phase-specific, community-oriented treatment of early psychosis an economically viable method of improving outcome?. Acta Psychiatrica Scandinavica 1999; 100(1)47–55
   PubMed Web of Science ®Google Scholar
• Miller TJ, McGlashan TH, Rosen JL, Somjee L, Markovich PJ, Stein K, et al. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: Preliminary evidence of interrater reliability and predictive validity. American Journal of Psychiatry 2002; 159(5)863–865
   PubMed Web of Science ®Google Scholar
• Mojtabai R, Malaspina D, Susser E. Concepts of population prevention: Application to schizophrenia. Schizophrenia Bulletin 2003; 29: 791–801
   PubMed Web of Science ®Google Scholar
• Moller P, Husby R. The initial prodrome in schizophrenia: Searching for naturalistic core dimensions of experience and behavior. Schizophrenia Bulletin 2000; 26(1)217–232
   PubMed Web of Science ®Google Scholar
• Morrison AP, Bentall RP, French P, Walford L, Kilcommons A, Knight A, et al. Randomised controlled trial of early detection and cognitive therapy for preventing transition to psychosis in high-risk individuals. Study design and interim analysis of transition rate and psychological risk factors. British Journal of Psychiatry 2002; 43(Suppl.)s78–s84
   Google Scholar
• Morrison AP, French P, Walford L, Lewis SW, Kilcommons A, Green J, et al. Cognitive therapy for the prevention of psychosis in people at ultra-high risk: Randomised controlled trial. British Journal of Psychiatry 2004; 185: 291–297
   PubMed Web of Science ®Google Scholar
• Mortensen PB, Pedersen CB, Westergaard T, Wohlfahrt J, Ewald H, et al. Effects of family history and place and season of birth on the risk of schizophrenia. New England Journal of Medicine 1999; 340: 603–608
   PubMed Web of Science ®Google Scholar
• Mrazek PJ, Haggerty RJ. Reducing risks for mental disorders: Frontiers for preventive intervention research. National Academy Press, Washington, DC 1994
   Google Scholar
• Mueser KT, McGurk SR. Schizophrenia. The Lancet 2004; 363: 2063–2072
   PubMed Web of Science ®Google Scholar
• Murray C, Lopez A. The global burden of disease. Harvard School of Public Health, WHO and World Bank, Boston 1996
   Google Scholar
• Murray CJ, Lopez AD, Mathers CD, Stein C. The global burden of disease 2000 project: Aims, methods and data sources. Harvard Burden of Disease Unit, Cambridge, MA 2001
   Google Scholar
• Murray RM, McGuffin P. Genetic aspects of psychiatric disorders. Companion to psychiatric studies5th, R Kendell, A Zeally. Churchill-Livingstone, Edinburgh 1993; 227–261
   Google Scholar
• Nordentoft M, Jeppesen P, Abel MB, Kassow P, Petersen L, Thorup A, et al. OPUS study: Suicidal behaviour, suicidal ideation and hopelessness among patients with first-episode psychosis. One-year follow-up of a randomised controlled trial. British Journal of Psychiatry 2002; 43(Suppl.)s98–s106
   Google Scholar
• Offord DR, Kraemer HC, Kazdin AE, Jensen PS, Harrington R. Lowering the burden of suffering from child psychiatric disorder: Trade-offs among clinical, targeted, and universal interventions. Journal of the American Academy of Child & Adolescent Psychiatry 1998; 37(7)686–694
   PubMed Web of Science ®Google Scholar
• Pantelis C, Yucel M, Wood SJ, McGorry PD, Velakoulis D. Early and late neurodevelopmental disturbances in schizophrenia and their functional consequences. Australian and New Zealand Journal of Psychiatry 2003; 37: 339–406
   Google Scholar
• Pantelis C, Yucel M, Wood SJ, Velakoulis D, Sun D, Berger G, et al. Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophrenia Bulletin 2005; 31: 672–696
   PubMed Web of Science ®Google Scholar
• Perkins DO, Gu H, Boteva K, Lieberman JA. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: A critical review and meta-analysis. American Journal of Psychiatry 2005; 162: 1785–1804
   PubMed Web of Science ®Google Scholar
• Petersen L, Jeppesen P, Thorup A, Abel MB, Ohlenschlaeger J, Christensen TO, et al. A randomised multicentre trial integrated versus standard treatment for patients with a first episode of psychotic illness. British Medical Journal 2005a; 331: 602–609
   PubMed Web of Science ®Google Scholar
• Petersen L, Nordentoft M, Jeppesen P, Ohlenschlaeger J, Thorup A, Christensen TO, et al. Improving 1-year outcome in first-episode psychosis: OPUS trial. British Journal of Psychiatry 2005b; 48(Suppl.)s98–s103
   Google Scholar
• Poulton R, Caspi A, Moffitt TE, Cannon M, Murray R, Harrington H. Children's self-reported psychotic symptoms and adult schizophreniform disorder: A 15-year longitudinal study. Archives of General Psychiatry 2000; 57(11)1053–1058
   PubMed Web of Science ®Google Scholar
• Power P. Suicide and early psychosis. The recognition and management of early psychosis: A preventive approach, PD McGorry, HJ Jackson. Cambridge University Press, New York 1999; 338–62
   Google Scholar
• Power PJR, Bell RJ, Mills R, Herrman-Doig T, Davern M, Henry L, et al. Suicide in prevention in first episode psychosis: The development of a randomised controlled trial of cognitive therapy for acutely suicidal patients with early psychosis. Australian and New Zealand Journal of Psychiatry 2003; 37: 414–420
   PubMed Web of Science ®Google Scholar
• Public Health Group. Victorian burden of disease study: Mortality and morbidity in 2001. Victorian Government Department of Human Services, Melbourne 2005
   Google Scholar
• Rabinowitz J, De Smedt G, Harvey PD, Davidson M. Relationship between premorbid functioning and symptom severity as assessed at first episode of psychosis. American Journal of Psychiatry 2002; 159: 2021–2026
   PubMed Web of Science ®Google Scholar
• Reichenberg A, Rabinowitz J, Weiser M, Mark M, Kaplan Z, Davidson M. Premorbid functioning in a national population of male twins discordant for psychoses. American Journal of Psychiatry 2000; 157: 1514–1516
   PubMed Web of Science ®Google Scholar
• Reichenberg A, Weiser M, Rabinowitz J, Caspi A, Schmeidler J, et al. A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder. American Journal of Psychiatry 2002; 159: 2027–2035
   PubMed Web of Science ®Google Scholar
• Rinaldi M, McNeil K, Firn M, Koletsi M, Perkins R, Singh S. What are the benefits of evidence-based supported employment for patients with first-episode psychosis?. Psychiatric Bulletin 2004; 28(8)281–284
   Google Scholar
• Rose G. The strategy of preventive medicine. Oxford University Press, Oxford 1992
   Google Scholar
• Ruhrmann S, Schultze-Lutter F, Klosterkotter J. Early detection and intervention in the initial prodromal phase of schizophrenia. Pharmacopsychiatry 2003; 36(Suppl. 3)s162–s167
   PubMedGoogle Scholar
• Ruhrmann S, Schultze-Lutter F, Maier W, Klosterkotter J. Pharmacological intervention in the initial prodromal phase of psychosis. European Psychiatry 2005; 20(1)1–6
   PubMedGoogle Scholar
• Ruhrmann S, Hoppmann B, Theysohn S, Picker H, Kuhn KU, Schultze-Lutter F, et al. Acute symptomatic treatment effects in persons clinically at risk for psychosis. Schizophrenia Research 2006; 86(Suppl.)s9
   Google Scholar
• SANE. Schizophrenia: Costs. An analysis of the burden of schizophrenia and related suicide in Australia. SANE, SydneyAustralia 2002
   Google Scholar
• Schultze-Lutter F, Wieneke A, Picker H, Rolff Y, Steinmeyer EM, Ruhrmann S, et al. The Schizophrenia Prediction Instrument, Adult Version (SPI-A). Schizophrenia Research 2004; 70/1S: 76–77
   Google Scholar
• Spataro J, Mullen PE, Burgess PM, Wells DL, Moss SA. Impact of child sexual abuse on mental health: Prospective study in males and females. British Journal of Psychiatry 2004; 184: 416–421
   PubMed Web of Science ®Google Scholar
• Spauwen J, Krabbendam L, Lieb R, Wittchen H-U, Van Os J. Evidence that the outcome of developmental expression of psychosis is worse for adolescents growing up in an urban environment. Psychological Medicine 2006; 36(3)407–415
   PubMedGoogle Scholar
• Tarrant CJ, Jones PB. The specificity of developmental precursors of schizophrenia and affective disorders. Psychiatric Annals 1999; 29(3)137–144
   Google Scholar
• Tarrier N, Lewis S, Haddock G, Bentall R, Drake R, Kinderman P, et al. Cognitive-behavioural therapy in first-episode and early schizophrenia. 18-month follow-up of a randomised controlled trial. British Journal of Psychiatry 2004; 184: 231–239
   PubMed Web of Science ®Google Scholar
• Thorup A, Petersen L, Jeppesen P, Ohlenschlaeger J, Christensen TO, Krarup G, et al. Integrated treatment ameliorates negative symptoms in first episode psychosis–results from the Danish OPUS trial. Schizophrenia Research 2005; 79: 95–105
   PubMed Web of Science ®Google Scholar
• Tien AY. Distributions of hallucinations in the population. Social Psychiatry & Psychiatric Epidemiology 1991; 26(6)287–292
   PubMed Web of Science ®Google Scholar
• Torrey EF, Miller J, Rawlings R, Yolken RH. Seasonality of births in schizophrenia and bipolar disorder: A review of the literature. Schizophrenia Research 1997; 28: 1–38
   PubMed Web of Science ®Google Scholar
• van Os J. Is there a continuum of psychotic experiences in the general population?. Epidemiologie Psichiatrica Sociale 2003; 12(4)242–252
   PubMedGoogle Scholar
• van Os J. Does the urban environment cause psychosis?. British Journal of Psychiatry 2004; 184(4)287–288
   PubMedGoogle Scholar
• van Os J, Hanssen M, de Graaf R, Vollebergh W. Does the urban environment independently increase the risk for both negative and positive features of psychosis?. Social Psychiatry & Psychiatric Epidemiology 2002; 37(10)460–464
   PubMed Web of Science ®Google Scholar
• van Os J, Hanssen M, Bak M, Bijl RV, Vollebergh W. Do urbanicity and familial liability co-participate in causing psychosis?. American Journal of Psychiatry 2003; 160: 477–482
   PubMedGoogle Scholar
• van Os J, McGuffin P. Can the social environment cause schizophrenia?. British Journal of Psychiatry 2003; 182: 291–292
   PubMed Web of Science ®Google Scholar
• Verdoux H, Cougnard A. Schizophrenia: Who is at risk? Who is a case?. International Clinical Psychopharmacology 2006; 21(Suppl. 2)s17–s19
   Google Scholar
• Warner R. The prevention of schizophrenia: What interventions are safe and effective. Schizophrenia Bulletin 2001; 27: 551–562
   PubMed Web of Science ®Google Scholar
• WHO. World health report 2001: Mental health, new understanding, new hope. World Health Organisation, Geneva 2001
   Google Scholar
• Wright A, McGorry PD, Harris MG, Jorm AF, Pennell K. Development and evaluation of a youth mental health community awareness campaign–The Compass Strategy. BMC Public Health 2006; 6: 215
   PubMed Web of Science ®Google Scholar
• Wood SJ, Berger GE, Lambert M, Conus P, Velakoulis D, Stuart GW, et al. prediction of functional outcome 18 months after a first psychotic episode: A proton magnetic resonance spectroscopy study. Archives of General Psychiatry 2006; 63: 969–976
   PubMedGoogle Scholar
• Wood SJ, Berger G, Velakoulis D, Phillips LJ, McGorry PD, et al. Proton magnetic resonance spectroscopy in first episode psychosis and ultra high risk individuals. Schizophrenia Bulletin 2003; 29: 831–843
   PubMed Web of Science ®Google Scholar
• Yao JK, Reddy RD, van Kammen DP. Oxidative damage and schizophrenia: An overview of the evidence and its therapeutic implications. CNS Drugs 2001; 15(4)287–310
   PubMed Web of Science ®Google Scholar
• Yung A, McGorry PD, McFarlane CA, Patton GC. The PACE clinic: Development of a clinical service for young people at high risk of psychosis. Australasian Psychiatry 1995; 3: 345–349
   Google Scholar
• Yung AR, McGorry PD. The prodromal phase of first-episode psychosis: Past and current conceptualizations. Schizophrenia Bulletin 1996; 22(2)353–370
   PubMed Web of Science ®Google Scholar
• Yung AR, McGorry PD, McFarlane CA, Jackson HJ, Patton GC, Rakkar A. Monitoring and care of young people at incipient risk of psychosis. Schizophrenia Bulletin 1996b; 22(2)283–303
   PubMed Web of Science ®Google Scholar
• Yung AR, McGorry PD. Is pre-psychotic intervention realistic in schizophrenia and related disorders?. Australian & New Zealand Journal of Psychiatry 1997; 31: 799–805
   PubMed Web of Science ®Google Scholar
• Yung AR, Phillips LJ, McGorry PD, McFarlane CA, Francey S, Harrigan SM, et al. Prediction of psychosis: A step towards indicated prevention of schizophrenia. British Journal of Psychiatry 1998; 172(Suppl. 33)s14–s20
   Google Scholar
• Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M, et al. Psychosis prediction: 12-month follow up of a high-risk (‘prodromal’) group. Schizophrenia Research 2003; 60(1)21–32
   PubMed Web of Science ®Google Scholar
• Yung A, McGorry P. Precursors of schizophrenia. Current Psychosis and Therapeutics Reports 2004; 2: 67–72
   Google Scholar
• Yung AR, Phillips LJ, McGorry PD. Treating schizophrenia in the prodromal phase. Taylor and Francis, London 2004a
   Google Scholar
• Yung AR, Phillips LJ, Yuen HP, McGorry PD. Risk factors for psychosis in an ultra high-risk group: Psychopathology and clinical features. Schizophrenia Research 2004b; 67(2–3)131–142
   PubMed Web of Science ®Google Scholar
• Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell'Olio M, et al. Mapping the onset of psychosis: The Comprehensive Assessment of At-Risk Mental States. Australian and New Zealand Journal of Psychiatry 2005; 39(11–12)964–971
   PubMed Web of Science ®Google Scholar
• Yung AR, Stanford C, Cosgrave E, Killackey E, Phillips L, Nelson B, et al. Testing the Ultra High Risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people. Schizophrenia Research 2006; 84(1)57–66
   PubMed Web of Science ®Google Scholar
• Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: Historical cohort study. British Medical Journal 2002; 325(7374)1199–1204
   PubMed Web of Science ®Google Scholar